Royal Bank of Canada vs Twist Bioscience Corp — how do they compare? Royal Bank of Canada trades at $210.37 (market cap $289.51B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Royal Bank of Canada is far larger — about 53.1× Twist Bioscience Corp's market cap, and Royal Bank of Canada pays a 2.42% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| RY | TWST | |
|---|---|---|
Market Cap | $289.51B | $5.45B |
Sector | Financials | Health |
52-Week High | $217.87 | $102.88 |
52-Week Low | $128.46 | $24.16 |
Dividend Yield | 2.42% | — |
Enterprise Value | — | $5.37B |
Trailing returns across standard periods
Latest headlines on both assets
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →